Coming Soon
Understanding Moderate Dementia: Find information on clinical documentation, medical coding (ICD-10 G31.84), diagnostic criteria, and healthcare management for patients with moderate stage dementia. Learn about cognitive assessment, care planning, and common symptoms associated with this stage of dementia progression. This resource provides guidance for healthcare professionals, caregivers, and individuals seeking information on moderate dementia diagnosis and support.
Also known as
Moderate neurocognitive disorder
Significant cognitive decline interfering with independence.
Unspecified dementia with disturbance of conduct
Dementia with behavioral issues, severity unspecified.
Alzheimer's disease, unspecified
Alzheimer's disease without further specification.
Other frontotemporal lobar degeneration
Deterioration of frontal and temporal brain lobes.
When to use each related code
| Description |
|---|
| Moderate Dementia |
| Mild Vascular Dementia |
| Dementia with Lewy Bodies |
Using unspecified dementia codes (e.g., F03.9) when clinical documentation supports moderate dementia (F02.1) leads to inaccurate severity reflection and reimbursement.
Missing documentation and coding of comorbidities associated with moderate dementia (e.g., depression, delirium) impacts risk adjustment and quality metrics.
Insufficient documentation of cognitive assessment results (e.g., MMSE scores) supporting moderate dementia diagnosis creates audit vulnerability and coding inaccuracies.
Patient presents with moderate dementia, characterized by progressive cognitive decline impacting daily function. Symptoms include significant memory impairment, particularly short-term memory loss, affecting activities of daily living (ADLs). Challenges with executive function, such as planning, organizing, and problem-solving, are evident. Behavioral and psychological symptoms of dementia (BPSD), including agitation, anxiety, and apathy, may be present. The patient exhibits diminished insight into their cognitive deficits. Assessment includes cognitive testing, such as the Mini-Mental State Examination (MMSE) or Montreal Cognitive Assessment (MoCA), revealing scores indicative of moderate impairment. Differential diagnosis considered vascular dementia, Alzheimer's disease, and Lewy body dementia. Current medications reviewed for potential cognitive impact. Caregiver support and education provided, addressing safety concerns and strategies for managing behavioral changes. Treatment plan includes non-pharmacological interventions like cognitive stimulation therapy and referral to occupational therapy for ADL support. Pharmacological interventions, such as cholinesterase inhibitors, may be considered to address cognitive symptoms. Follow-up scheduled to monitor disease progression and adjust treatment as needed. ICD-10 code F03.9 (Unspecified dementia) or more specific code if etiology confirmed, for example G30.9 (Alzheimer's disease, unspecified), with appropriate modifiers if applicable. CPT codes for evaluation and management (E M) services documented, reflecting the complexity of the encounter. Referral to neurology or geriatrics may be warranted for further diagnostic workup and specialized management.